4.4 Article

Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3

Journal

JOURNAL OF GENERAL VIROLOGY
Volume 92, Issue -, Pages 2394-2398

Publisher

SOC GENERAL MICROBIOLOGY
DOI: 10.1099/vir.0.034322-0

Keywords

-

Funding

  1. Cancer Research UK [C7934]
  2. MRC [G0800154, G0400408]
  3. Government of Ghana Education Trust
  4. University of Warwick
  5. MRC [G0800154, G0400408, G0401584] Funding Source: UKRI
  6. Medical Research Council [G0401584, G0400408, G0800154] Funding Source: researchfish

Ask authors/readers for more resources

Kaposi's sarcoma-associated herpesvirus (KSHV) encodes four viral interferon regulatory factors (vIRF-1-4). We investigated the mechanism and consequences of vIRF-2-mediated inhibition of interferon-response element signalling following type 1 interferon (IFN) induction. Western blot and electrophoretic mobility-shift assays identified the interferon-stimulated gene factor-3 (ISGF-3) components STAT1 and IRF-9 as the proximal targets of vIRF-2 activity. The biological significance of vIRF-2 inhibition of ISGF-3 was demonstrated by vIRF-2-mediated rescue of the replication of the IFN-sensitive virus encephalomyocarditis virus. This study provides both a mechanism and evidence for KSHV vIRF-2-mediated suppression of the consequences of type 1 IFN-induced signalling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available